1910 Genetics
Curated by SignalDeveloper of small molecule therapeutics to treat pain and aging-related diseases
Overview
Developer of small molecule therapeutics to treat pain and aging-related diseases. It is a biotechnology company that integrates AI, computation, and biological automation to accelerate the design of small molecule and protein therapeutics. The company have developed two discovery engines ELVIS and ROSALYND that enable to design drug candidates.
Key facts
- Founded
- 2018
- Headquarters
- Cambridge, United States
- Stage
- Sign up to view
- Industry
- Health Technology
Business model
- 4 products and services
- Sign up to view
- Commercial model
- Sign up to view
Contact
- Sign up to view